ID   DAAF4_HUMAN             Reviewed;         420 AA.
AC   Q8WXU2; Q6P5Y9; Q8N1S6;
DT   21-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   07-APR-2021, entry version 177.
DE   RecName: Full=Dynein assembly factor 4, axonemal {ECO:0000312|HGNC:HGNC:21493};
DE   AltName: Full=Dyslexia susceptibility 1 candidate gene 1 protein;
GN   Name=DNAAF4 {ECO:0000312|HGNC:HGNC:21493}; Synonyms=DYX1C1, EKN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, CHROMOSOMAL TRANSLOCATION, AND VARIANTS SER-2; ILE-91; GLY-191
RP   AND CYS-420.
RX   PubMed=12954984; DOI=10.1073/pnas.1833911100;
RA   Taipale M., Kaminen N., Nopola-Hemmi J., Haltia T., Myllyluoma B.,
RA   Lyytinen H., Muller K., Kaaranen M., Lindsberg P.J., Hannula-Jouppi K.,
RA   Kere J.;
RT   "A candidate gene for developmental dyslexia encodes a nuclear
RT   tetratricopeptide repeat domain protein dynamically regulated in brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:11553-11558(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS GLY-191
RP   AND VAL-332.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16989952; DOI=10.1016/j.neuroscience.2006.08.022;
RA   Wang Y., Paramasivam M., Thomas A., Bai J., Kaminen-Ahola N., Kere J.,
RA   Voskuil J., Rosen G.D., Galaburda A.M., Loturco J.J.;
RT   "DYX1C1 functions in neuronal migration in developing neocortex.";
RL   Neuroscience 143:515-522(2006).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH ESR1 AND STUB1.
RX   PubMed=19423554; DOI=10.1093/hmg/ddp215;
RA   Massinen S., Tammimies K., Tapia-Paez I., Matsson H., Hokkanen M.E.,
RA   Soederberg O., Landegren U., Castren E., Gustafsson J.A., Treuter E.,
RA   Kere J.;
RT   "Functional interaction of DYX1C1 with estrogen receptors suggests
RT   involvement of hormonal pathways in dyslexia.";
RL   Hum. Mol. Genet. 18:2802-2812(2009).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH DNAAF2, AND INVOLVEMENT IN
RP   CILD25.
RX   PubMed=23872636; DOI=10.1038/ng.2707;
RA   Tarkar A., Loges N.T., Slagle C.E., Francis R., Dougherty G.W.,
RA   Tamayo J.V., Shook B., Cantino M., Schwartz D., Jahnke C., Olbrich H.,
RA   Werner C., Raidt J., Pennekamp P., Abouhamed M., Hjeij R., Kohler G.,
RA   Griese M., Li Y., Lemke K., Klena N., Liu X., Gabriel G., Tobita K.,
RA   Jaspers M., Morgan L.C., Shapiro A.J., Letteboer S.J., Mans D.A.,
RA   Carson J.L., Leigh M.W., Wolf W.E., Chen S., Lucas J.S., Onoufriadis A.,
RA   Plagnol V., Schmidts M., Boldt K., Roepman R., Zariwala M.A., Lo C.W.,
RA   Mitchison H.M., Knowles M.R., Burdine R.D., Loturco J.J., Omran H.;
RT   "DYX1C1 is required for axonemal dynein assembly and ciliary motility.";
RL   Nat. Genet. 45:995-1003(2013).
RN   [8]
RP   INVOLVEMENT IN CILD25.
RX   PubMed=25186273; DOI=10.1183/09031936.00052014;
RA   Raidt J., Wallmeier J., Hjeij R., Onnebrink J.G., Pennekamp P., Loges N.T.,
RA   Olbrich H., Haeffner K., Dougherty G.W., Omran H., Werner C.;
RT   "Ciliary beat pattern and frequency in genetic variants of primary ciliary
RT   dyskinesia.";
RL   Eur. Respir. J. 44:1579-1588(2014).
RN   [9]
RP   INTERACTION WITH DNAAF6.
RX   PubMed=28041644; DOI=10.1016/j.ajhg.2016.11.019;
RA   Paff T., Loges N.T., Aprea I., Wu K., Bakey Z., Haarman E.G., Daniels J.M.,
RA   Sistermans E.A., Bogunovic N., Dougherty G.W., Hoeben I.M.,
RA   Grosse-Onnebrink J., Matter A., Olbrich H., Werner C., Pals G.,
RA   Schmidts M., Omran H., Micha D.;
RT   "Mutations in PIH1D3 Cause X-Linked Primary Ciliary Dyskinesia with Outer
RT   and Inner Dynein Arm Defects.";
RL   Am. J. Hum. Genet. 100:160-168(2017).
RN   [10]
RP   INTERACTION WITH ZMYND10.
RX   PubMed=29601588; DOI=10.1371/journal.pgen.1007316;
RA   Cho K.J., Noh S.H., Han S.M., Choi W.I., Kim H.Y., Yu S., Lee J.S.,
RA   Rim J.H., Lee M.G., Hildebrandt F., Gee H.Y.;
RT   "ZMYND10 stabilizes intermediate chain proteins in the cytoplasmic pre-
RT   assembly of dynein arms.";
RL   PLoS Genet. 14:E1007316-E1007316(2018).
CC   -!- FUNCTION: Axonemal dynein assembly factor required for ciliary
CC       motility. Involved in neuronal migration during development of the
CC       cerebral neocortex. May regulate the stability and proteasomal
CC       degradation of the estrogen receptors that play an important role in
CC       neuronal differentiation, survival and plasticity.
CC       {ECO:0000269|PubMed:19423554, ECO:0000269|PubMed:23872636}.
CC   -!- SUBUNIT: Interacts with ZMYND10 (PubMed:29601588). Interacts with ESR1
CC       and ESR2 (PubMed:19423554). Interacts with STUB1 (PubMed:19423554).
CC       Interacts with DNAAF2 (PubMed:23872636). Interacts with CCT3, CCT4,
CC       CCT5 and CCT8 (By similarity). Interacts with DNAAF6/PIH1D3
CC       (PubMed:28041644). {ECO:0000250|UniProtKB:Q8R368,
CC       ECO:0000269|PubMed:19423554, ECO:0000269|PubMed:23872636,
CC       ECO:0000269|PubMed:28041644, ECO:0000269|PubMed:29601588}.
CC   -!- INTERACTION:
CC       Q8WXU2; O95166: GABARAP; NbExp=4; IntAct=EBI-2946907, EBI-712001;
CC       Q8WXU2; Q9H0R8: GABARAPL1; NbExp=2; IntAct=EBI-2946907, EBI-746969;
CC       Q8WXU2; P60520: GABARAPL2; NbExp=2; IntAct=EBI-2946907, EBI-720116;
CC       Q8WXU2; Q9BXW4: MAP1LC3C; NbExp=2; IntAct=EBI-2946907, EBI-2603996;
CC       Q8WXU2; Q96EA4: SPDL1; NbExp=3; IntAct=EBI-2946907, EBI-715381;
CC       Q8WXU2-2; Q9H503-2: BANF2; NbExp=3; IntAct=EBI-9381887, EBI-11977289;
CC       Q8WXU2-2; P23508: MCC; NbExp=3; IntAct=EBI-9381887, EBI-307531;
CC       Q8WXU2-2; Q96EA4: SPDL1; NbExp=3; IntAct=EBI-9381887, EBI-715381;
CC       Q8WXU2-2; Q9UNE7: STUB1; NbExp=3; IntAct=EBI-9381887, EBI-357085;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12954984,
CC       ECO:0000269|PubMed:16989952}. Cytoplasm {ECO:0000269|PubMed:12954984,
CC       ECO:0000269|PubMed:16989952, ECO:0000269|PubMed:23872636}. Dynein
CC       axonemal particle {ECO:0000305|PubMed:23872636}. Cell projection,
CC       neuron projection {ECO:0000250|UniProtKB:Q5VJS5}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8WXU2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WXU2-2; Sequence=VSP_011822, VSP_011823;
CC       Name=3;
CC         IsoId=Q8WXU2-3; Sequence=VSP_041379;
CC   -!- TISSUE SPECIFICITY: Expressed in several tissues, including brain,
CC       lung, kidney and testis. In brain localizes to a fraction of cortical
CC       neurons and white matter glial cells. {ECO:0000269|PubMed:12954984}.
CC   -!- DISEASE: Dyslexia 1 (DYX1) [MIM:127700]: A relatively common, complex
CC       cognitive disorder characterized by an impairment of reading
CC       performance despite adequate motivational, educational and intellectual
CC       opportunities. It is a multifactorial trait, with evidence for familial
CC       clustering and heritability. Note=Disease susceptibility is associated
CC       with variants affecting the gene represented in this entry. A
CC       chromosomal aberration involving DNAAF4 has been found in a family
CC       affected by dyslexia. Translocation t(2;15)(q11;q21).
CC   -!- DISEASE: Ciliary dyskinesia, primary, 25 (CILD25) [MIM:615482]: A
CC       disorder characterized by abnormalities of motile cilia. Respiratory
CC       infections leading to chronic inflammation and bronchiectasis are
CC       recurrent, due to defects in the respiratory cilia. Patients may
CC       exhibit randomization of left-right body asymmetry and situs inversus,
CC       due to dysfunction of monocilia at the embryonic node. Primary ciliary
CC       dyskinesia associated with situs inversus is referred to as Kartagener
CC       syndrome. {ECO:0000269|PubMed:23872636, ECO:0000269|PubMed:25186273}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF337549; AAL73230.1; -; mRNA.
DR   EMBL; AK095201; BAC04498.1; -; mRNA.
DR   EMBL; AC013355; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022083; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC062564; AAH62564.1; -; mRNA.
DR   CCDS; CCDS10154.1; -. [Q8WXU2-1]
DR   CCDS; CCDS32243.1; -. [Q8WXU2-2]
DR   CCDS; CCDS32244.1; -. [Q8WXU2-3]
DR   RefSeq; NP_001028731.1; NM_001033559.2. [Q8WXU2-3]
DR   RefSeq; NP_001028732.1; NM_001033560.1. [Q8WXU2-2]
DR   RefSeq; NP_570722.2; NM_130810.3. [Q8WXU2-1]
DR   SMR; Q8WXU2; -.
DR   BioGRID; 127797; 18.
DR   IntAct; Q8WXU2; 16.
DR   MINT; Q8WXU2; -.
DR   STRING; 9606.ENSP00000323275; -.
DR   iPTMnet; Q8WXU2; -.
DR   PhosphoSitePlus; Q8WXU2; -.
DR   BioMuta; DNAAF4; -.
DR   DMDM; 209572610; -.
DR   jPOST; Q8WXU2; -.
DR   MassIVE; Q8WXU2; -.
DR   MaxQB; Q8WXU2; -.
DR   PaxDb; Q8WXU2; -.
DR   PeptideAtlas; Q8WXU2; -.
DR   PRIDE; Q8WXU2; -.
DR   ProteomicsDB; 75102; -. [Q8WXU2-1]
DR   ProteomicsDB; 75103; -. [Q8WXU2-2]
DR   ProteomicsDB; 75104; -. [Q8WXU2-3]
DR   Antibodypedia; 51982; 270 antibodies.
DR   Ensembl; ENST00000321149; ENSP00000323275; ENSG00000256061. [Q8WXU2-1]
DR   Ensembl; ENST00000348518; ENSP00000299561; ENSG00000256061. [Q8WXU2-1]
DR   Ensembl; ENST00000448430; ENSP00000403412; ENSG00000256061. [Q8WXU2-2]
DR   Ensembl; ENST00000457155; ENSP00000402640; ENSG00000256061. [Q8WXU2-3]
DR   GeneID; 161582; -.
DR   KEGG; hsa:161582; -.
DR   UCSC; uc002adc.3; human. [Q8WXU2-1]
DR   CTD; 161582; -.
DR   DisGeNET; 161582; -.
DR   GeneCards; DNAAF4; -.
DR   GeneReviews; DNAAF4; -.
DR   HGNC; HGNC:21493; DNAAF4.
DR   HPA; ENSG00000256061; Tissue enhanced (pituitary).
DR   MalaCards; DNAAF4; -.
DR   MIM; 127700; phenotype.
DR   MIM; 608706; gene.
DR   MIM; 615482; phenotype.
DR   neXtProt; NX_Q8WXU2; -.
DR   OpenTargets; ENSG00000256061; -.
DR   Orphanet; 244; Primary ciliary dyskinesia.
DR   PharmGKB; PA134870600; -.
DR   VEuPathDB; HostDB:ENSG00000256061.7; -.
DR   eggNOG; KOG1124; Eukaryota.
DR   GeneTree; ENSGT00390000004930; -.
DR   HOGENOM; CLU_029084_0_0_1; -.
DR   InParanoid; Q8WXU2; -.
DR   OMA; DAEKIRH; -.
DR   OrthoDB; 1485667at2759; -.
DR   PhylomeDB; Q8WXU2; -.
DR   TreeFam; TF328983; -.
DR   PathwayCommons; Q8WXU2; -.
DR   BioGRID-ORCS; 161582; 3 hits in 999 CRISPR screens.
DR   ChiTaRS; DYX1C1; human.
DR   GeneWiki; DYX1C1; -.
DR   GenomeRNAi; 161582; -.
DR   Pharos; Q8WXU2; Tbio.
DR   PRO; PR:Q8WXU2; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q8WXU2; protein.
DR   Bgee; ENSG00000256061; Expressed in bronchial epithelial cell and 152 other tissues.
DR   ExpressionAtlas; Q8WXU2; baseline and differential.
DR   Genevisible; Q8WXU2; HS.
DR   GO; GO:0005813; C:centrosome; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005576; C:extracellular region; IEA:GOC.
DR   GO; GO:0097730; C:non-motile cilium; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0030331; F:estrogen receptor binding; IDA:UniProtKB.
DR   GO; GO:0003341; P:cilium movement; IMP:UniProtKB.
DR   GO; GO:0007368; P:determination of left/right symmetry; IMP:UniProtKB.
DR   GO; GO:0003351; P:epithelial cilium movement involved in extracellular fluid movement; IBA:GO_Central.
DR   GO; GO:0007507; P:heart development; IBA:GO_Central.
DR   GO; GO:0036159; P:inner dynein arm assembly; IMP:UniProtKB.
DR   GO; GO:0001764; P:neuron migration; ISS:UniProtKB.
DR   GO; GO:0036158; P:outer dynein arm assembly; IMP:UniProtKB.
DR   GO; GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0061136; P:regulation of proteasomal protein catabolic process; IDA:UniProtKB.
DR   CDD; cd06469; p23_DYX1C1_like; 1.
DR   Gene3D; 1.25.40.10; -; 1.
DR   Gene3D; 2.60.40.790; -; 1.
DR   InterPro; IPR007052; CS_dom.
DR   InterPro; IPR037894; CS_DYX1C1.
DR   InterPro; IPR008978; HSP20-like_chaperone.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   Pfam; PF04969; CS; 1.
DR   SMART; SM00028; TPR; 3.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   SUPFAM; SSF49764; SSF49764; 1.
DR   PROSITE; PS51203; CS; 1.
DR   PROSITE; PS50005; TPR; 3.
DR   PROSITE; PS50293; TPR_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Chromosomal rearrangement;
KW   Ciliopathy; Cytoplasm; Kartagener syndrome; Neurogenesis; Nucleus;
KW   Primary ciliary dyskinesia; Reference proteome; Repeat; TPR repeat.
FT   CHAIN           1..420
FT                   /note="Dynein assembly factor 4, axonemal"
FT                   /id="PRO_0000106284"
FT   DOMAIN          3..87
FT                   /note="CS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00547"
FT   REPEAT          290..323
FT                   /note="TPR 1"
FT   REPEAT          324..357
FT                   /note="TPR 2"
FT   REPEAT          366..399
FT                   /note="TPR 3"
FT   REGION          7..103
FT                   /note="Mediates interaction with ESR1 and STUB1"
FT                   /evidence="ECO:0000269|PubMed:19423554"
FT   VAR_SEQ         350..381
FT                   /note="ALELLMPPVTDNANARMKAHVRRGTAFCQLEL -> EFCSLEGIECQASEPK
FT                   LSHHIPSDLHVYIQMA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011822"
FT   VAR_SEQ         351..420
FT                   /note="LELLMPPVTDNANARMKAHVRRGTAFCQLELYVEGLQDYEAALKIDPSNKIV
FT                   QIDAEKIRNVIQGTELKS -> YRIMKRHLRLIHPTKLYKLMLRRFGM (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_041379"
FT   VAR_SEQ         382..420
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011823"
FT   VARIANT         2
FT                   /note="P -> S (in dbSNP:rs143493699)"
FT                   /evidence="ECO:0000269|PubMed:12954984"
FT                   /id="VAR_017383"
FT   VARIANT         38
FT                   /note="N -> K (in dbSNP:rs16976354)"
FT                   /id="VAR_026214"
FT   VARIANT         91
FT                   /note="V -> I (in dbSNP:rs17819126)"
FT                   /evidence="ECO:0000269|PubMed:12954984"
FT                   /id="VAR_017384"
FT   VARIANT         191
FT                   /note="E -> G (in dbSNP:rs600753)"
FT                   /evidence="ECO:0000269|PubMed:12954984,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_017385"
FT   VARIANT         332
FT                   /note="A -> V (in dbSNP:rs17855756)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_026215"
FT   VARIANT         420
FT                   /note="S -> C (in dbSNP:rs77641439)"
FT                   /evidence="ECO:0000269|PubMed:12954984"
FT                   /id="VAR_017386"
SQ   SEQUENCE   420 AA;  48527 MW;  6B8729B3F4ED5108 CRC64;
     MPLQVSDYSW QQTKTAVFLS LPLKGVCVRD TDVFCTENYL KVNFPPFLFE AFLYAPIDDE
     SSKAKIGNDT IVFTLYKKEA AMWETLSVTG VDKEMMQRIR EKSILQAQER AKEATEAKAA
     AKREDQKYAL SVMMKIEEEE RKKIEDMKEN ERIKATKALE AWKEYQRKAE EQKKIQREEK
     LCQKEKQIKE ERKKIKYKSL TRNLASRNLA PKGRNSENIF TEKLKEDSIP APRSVGSIKI
     NFTPRVFPTA LRESQVAEEE EWLHKQAEAR RAMNTDIAEL CDLKEEEKNP EWLKDKGNKL
     FATENYLAAI NAYNLAIRLN NKMPLLYLNR AACHLKLKNL HKAIEDSSKA LELLMPPVTD
     NANARMKAHV RRGTAFCQLE LYVEGLQDYE AALKIDPSNK IVQIDAEKIR NVIQGTELKS
//
